Global Pelvic Inflammatory Disease (PID) Treatment Market Growth Prospects and Strategic Opportunities Through 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Pelvic Inflammatory Disease (PID) Treatment Market Expected To Grow In Terms Of Size?
In recent years, the size of the market for pelvic inflammatory disease (pid) treatment has seen robust growth. The market value, projected to rise from $4.49 billion in 2024 to $4.74 billion in 2025, will experience a compound annual growth rate (CAGR) of 5.5%. The historic period’s growth is due to factors such as the widening acceptance of telemedicine, a growing number of sexually transmitted infections, increased awareness about pelvic inflammatory disease, and higher healthcare spending.
An increase in size is anticipated in the pelvic inflammatory disease (pid) treatment market, with strong growth expected in the coming years. The market is predicted to inflate to $5.84 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. This progress during the forecasted period can be tied to factors such as the escalating prevalence of sexually transmitted diseases, increased cognizance of women’s reproductive wellness, enhanced awareness about pelvic inflammatory disease, a growing dependency on telehealth facilities, and an upward trajectory in the occurrence of sexually transmitted diseases (STIs). The forecasted period is identified by key trends that include the introduction of innovative treatments for pelvic inflammatory disease, advances in diagnostic technology, novel concepts like individualised treatment, state-of-the-art imaging techniques, and technological evolution.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21251&type=smp
Which Key Factors Are Fueling Growth In The Pelvic Inflammatory Disease (PID) Treatment Market?
The escalating instances of sexually transmitted infections (STIs) are set to bolster the pelvic inflammatory disease (PID) treatment market’s expansion. STIs are infections primarily transmitted through sexual contact, including vaginal, anal, or oral sex, and are caused by bacteria, viruses, or parasites. The surge in STIs is attributed to behaviors such as unprotected sex, risk-taking in sexual matters, inadequate awareness, and delays in testing and treatment. PID treatment, which utilizes antibiotics to eradicate infection-causing bacteria, is valuable in managing STIs. It helps fend off complications like chronic pelvic pain and infertility and reduces recurrent infection chances. For example, in October 2024, the UK Health Security Agency (UKHSA), a UK government agency, published a report stating a 51% increase in new human immunodeficiency virus (HIV) diagnoses in 2023, with a recorded 6,008 cases compared to 3,975 in 2022. Therefore, the rising instances of STIs are fueling the PID treatment market’s growth.
How Is The Pelvic Inflammatory Disease (PID) Treatment Market Categorized Across Applications And Types?
The pelvic inflammatory disease (pid) treatmentmarket covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy; Surgery; Pain Management; Hormonal Therapy
2) By Route Of Administration: Oral; Intravenous; Intramuscular
3) By End User: Hospitals; Clinics; Homecare
Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics; Combination Antibiotic Therapy; Oral Antibiotics; Intravenous Antibiotics
2) By Surgery: Laparoscopy; Hysterectomy; Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioid Analgesics; Acetaminophen; Localized Pain Management
4) By Hormonal Therapy: Birth Control Pills; Hormonal Intrauterine Device (IUD); Progesterone Therapy
Which Emerging Trends Are Reshaping The Pelvic Inflammatory Disease (PID) Treatment Market Landscape?
Major companies in the pelvic inflammatory disease (PID) treatment market are focusing on novel formulations such as probiotic supplements to improve treatment effectiveness, restore vaginal microbiota balance, and reduce infection recurrence. Probiotic supplements contain beneficial live bacteria or yeasts that support healthy gut and vaginal flora. For instance, in November 2024, Lee Health Domain, an India-based pharmaceutical company, launched V-Ferin, a probiotic supplement formulated with Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract to support vaginal health. V-Ferin aims to restore natural microbiome balance and prevent infections like bacterial vaginosis and yeast infections, which affect about 25-30% of women and can lead to PID if untreated. This product offers a new approach to improving vaginal health and preventing complications.
Which Firms Are Making The Biggest Impact In The Pelvic Inflammatory Disease (PID) Treatment Market?
Major companies operating in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., Amagen India Life Sciences.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Pelvic Inflammatory Disease (PID) Treatment Market Expansion?
North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pelvic inflammatory disease (PID) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21251&type=smp
Browse Through More Reports Similar to the Global Pelvic Inflammatory Disease (PID) Treatment Market 2025, By The Business Research Company
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2025
Inflammatory Bowel Disease Treatment Global Market Report 2025
Non Steroidal Anti Inflammatory Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
